Global Dendritic Cell Cancer Vaccines Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 103

Report ID: 3560

Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo and administered as a cellular vaccine are found to induce protective and therapeutic anti-tumor immunity in experimental animals.
Increase in prevalence of cancer, improvement of technology such as drug innovations regarding cancer, upsurge in awareness about cancer and their available therapies in the market, and increase in health care expenditure drive the market.
In 2018, the global Dendritic Cell Cancer Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Dendritic Cell Cancer Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dendritic Cell Cancer Vaccines development in United States, Europe and China.

The key players covered in this study
3M Company
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck
Northwest Biotherapeutics
Glaxo Smith Kline
Tellaorporation
Vaxil BioTherapeutics

Market segment by Type, the product can be split into
CreaVax
Sipuleucel-T (Provenge)
Others

Market segment by Application, split into
Pediatrics
Adults

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Dendritic Cell Cancer Vaccines status, future forecast, growth opportunity, key market and key players.
To present the Dendritic Cell Cancer Vaccines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Dendritic Cell Cancer Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dendritic Cell Cancer Vaccines Market Size Growth Rate by Type (2014-2025)
1.4.2 CreaVax
1.4.3 Sipuleucel-T (Provenge)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Dendritic Cell Cancer Vaccines Market Share by Application (2014-2025)
1.5.2 Pediatrics
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Dendritic Cell Cancer Vaccines Market Size
2.2 Dendritic Cell Cancer Vaccines Growth Trends by Regions
2.2.1 Dendritic Cell Cancer Vaccines Market Size by Regions (2014-2025)
2.2.2 Dendritic Cell Cancer Vaccines Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Dendritic Cell Cancer Vaccines Market Size by Manufacturers
3.1.1 Global Dendritic Cell Cancer Vaccines Revenue by Manufacturers (2014-2019)
3.1.2 Global Dendritic Cell Cancer Vaccines Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Dendritic Cell Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Dendritic Cell Cancer Vaccines Key Players Head office and Area Served
3.3 Key Players Dendritic Cell Cancer Vaccines Product/Solution/Service
3.4 Date of Enter into Dendritic Cell Cancer Vaccines Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019)
4.2 Global Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019)

5 United States
5.1 United States Dendritic Cell Cancer Vaccines Market Size (2014-2019)
5.2 Dendritic Cell Cancer Vaccines Key Players in United States
5.3 United States Dendritic Cell Cancer Vaccines Market Size by Type
5.4 United States Dendritic Cell Cancer Vaccines Market Size by Application

6 Europe
6.1 Europe Dendritic Cell Cancer Vaccines Market Size (2014-2019)
6.2 Dendritic Cell Cancer Vaccines Key Players in Europe
6.3 Europe Dendritic Cell Cancer Vaccines Market Size by Type
6.4 Europe Dendritic Cell Cancer Vaccines Market Size by Application

7 China
7.1 China Dendritic Cell Cancer Vaccines Market Size (2014-2019)
7.2 Dendritic Cell Cancer Vaccines Key Players in China
7.3 China Dendritic Cell Cancer Vaccines Market Size by Type
7.4 China Dendritic Cell Cancer Vaccines Market Size by Application

8 Japan
8.1 Japan Dendritic Cell Cancer Vaccines Market Size (2014-2019)
8.2 Dendritic Cell Cancer Vaccines Key Players in Japan
8.3 Japan Dendritic Cell Cancer Vaccines Market Size by Type
8.4 Japan Dendritic Cell Cancer Vaccines Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Dendritic Cell Cancer Vaccines Market Size (2014-2019)
9.2 Dendritic Cell Cancer Vaccines Key Players in Southeast Asia
9.3 Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Type
9.4 Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Application

10 India
10.1 India Dendritic Cell Cancer Vaccines Market Size (2014-2019)
10.2 Dendritic Cell Cancer Vaccines Key Players in India
10.3 India Dendritic Cell Cancer Vaccines Market Size by Type
10.4 India Dendritic Cell Cancer Vaccines Market Size by Application

11 Central & South America
11.1 Central & South America Dendritic Cell Cancer Vaccines Market Size (2014-2019)
11.2 Dendritic Cell Cancer Vaccines Key Players in Central & South America
11.3 Central & South America Dendritic Cell Cancer Vaccines Market Size by Type
11.4 Central & South America Dendritic Cell Cancer Vaccines Market Size by Application

12 International Players Profiles
12.1 3M Company
12.1.1 3M Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dendritic Cell Cancer Vaccines Introduction
12.1.4 3M Company Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.1.5 3M Company Recent Development
12.2 Activarti
12.2.1 Activarti Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dendritic Cell Cancer Vaccines Introduction
12.2.4 Activarti Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.2.5 Activarti Recent Development
12.3 Argos Therapeutics
12.3.1 Argos Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dendritic Cell Cancer Vaccines Introduction
12.3.4 Argos Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.3.5 Argos Therapeutics Recent Development
12.4 Batavia Bioservices
12.4.1 Batavia Bioservices Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dendritic Cell Cancer Vaccines Introduction
12.4.4 Batavia Bioservices Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.4.5 Batavia Bioservices Recent Development
12.5 Bellicum Pharmaceuticals
12.5.1 Bellicum Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dendritic Cell Cancer Vaccines Introduction
12.5.4 Bellicum Pharmaceuticals Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.5.5 Bellicum Pharmaceuticals Recent Development
12.6 Creagene
12.6.1 Creagene Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dendritic Cell Cancer Vaccines Introduction
12.6.4 Creagene Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.6.5 Creagene Recent Development
12.7 DanDrit Biotech
12.7.1 DanDrit Biotech Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dendritic Cell Cancer Vaccines Introduction
12.7.4 DanDrit Biotech Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.7.5 DanDrit Biotech Recent Development
12.8 DCPrime
12.8.1 DCPrime Company Details
12.8.2 Company Description and Business Overview
12.8.3 Dendritic Cell Cancer Vaccines Introduction
12.8.4 DCPrime Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.8.5 DCPrime Recent Development
12.9 Sanpower Corporation
12.9.1 Sanpower Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Dendritic Cell Cancer Vaccines Introduction
12.9.4 Sanpower Corporation Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.9.5 Sanpower Corporation Recent Development
12.10 Elios Therapeutics
12.10.1 Elios Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Dendritic Cell Cancer Vaccines Introduction
12.10.4 Elios Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.10.5 Elios Therapeutics Recent Development
12.11 ImmunoCellular Therapeutics
12.12 Immunicum
12.13 Kiromic
12.14 Medigene
12.15 Merck
12.16 Northwest Biotherapeutics
12.17 Glaxo Smith Kline
12.18 Tellaorporation
12.19 Vaxil BioTherapeutics

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details